January 5, 2017Biomarkers

CRP velocity and short-term mortality in ST segment elevation myocardial infarction

View Full Paper

Ask AI

Bookmark

Why the study?

Does C-reactive protein velocity (CRPv) predict 30-day mortality in patients presenting with STEMI?

Population

492 consecutive patients with a diagnosis of ST-elevation myocardial infarction who had their CRP measured…

Design

Cohort

Follow-up

30 days

Authors

AMAssi MilwidskyHeart Failure & Transplant TZTomer Ziv‐BaranTel Aviv University SLSevan Letourneau-ShesafCedars-Sinai Medical Center

Discussion

Member takes

Implication

CRPv may refine 30-day risk stratification in STEMI; leaves open incremental value and need for validation.

Structured PICO

Does C-reactive protein velocity (CRPv) predict 30-day mortality in patients presenting with STEMI?

Population

492 consecutive patients with a diagnosis of ST-elevation myocardial infarction (STEMI) who had their CRP measured with a wide range assay at least twice during the 24 h after admission, mean age 62 ± 14, 80% male.

Intervention

C-reactive protein velocity (CRPv), defined as the change in wr-CRP concentration (mg/l) divided by the change in time (in hours) between two measurements within 24 hours of admission.

Outcome

30-day mortalityhard clinical

C-reactive protein velocity measured within the first 24 hours of admission is an independent predictor of 30-day mortality in patients with STEMI.

Cite This Study

Milwidsky et al. (2017) studied this question.

synapsesocial.com/papers/6a72f314bfabfe3aef60db74 https://doi.org/10.1080/1354750x.2017.1279218

Topics

STEMI management

View Full Paper

Ask AI

Bookmark

CRP velocity and short-term mortality in ST segment elevation myocardial infarction

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

CRP velocity and short-term mortality in ST segment elevation myocardial infarction

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider